Aardvark Therapeutics, Inc. Common Stock reported earnings of -$ 0.88 per AARD share on Nov 13, 2026, beating analysts' expectations by
| Report Date | Nov 13, 2026 |
|---|---|
| Forecasted EPS | -$ 0.72 |
| Earnings Per Share (Surprise) | -$ 0.88 (-$ 0.16) |
| Last Year's EPS | -$ 0.73 |
| EPS YoY Change |
Out of the last 14 earnings reporting periods, Aardvark Therapeutics, Inc. Common Stock beat analysts’ expectations 3 times and fell short of expectations 6 time(s). Aardvark Therapeutics, Inc. Common Stock reported earnings per share of -$ 0.88 in the last report falling to reach an estimated EPS of -$ 0.72 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 0.72 | -$ 0.88 | -$ 0.75 | |
| Aug 11, 2026 | -$ 0.87 | -$ 0.66 | -$ 0.66 | |
| May 7, 2026 | -$ 0.88 | -$ 0.99 | -$ 0.71 | |
| Mar 23, 2026 | -$ 0.83 | -$ 0.81 | -$ 0.44 | |
| Nov 13, 2025 | -$ 0.80 | -$ 0.75 | -$ 0.68 | |
| Aug 13, 2025 | -$ 0.60 | -$ 0.66 | -$ 0.32 | |
| May 14, 2025 | -$ 0.67 | -$ 0.71 | -$ 2.13 | |
| Mar 31, 2025 | -$ 0.41 | -$ 0.44 | -$ 0.17 | |
| Feb 26, 2025 | -$ 0.41 | -$ 0.68 | -$ 0.21 | |
| Sep 30, 2024 | - | -$ 0.32 | -$ 0.22 | |
| Jun 30, 2024 | - | -$ 2.13 | - | - |
| Mar 31, 2024 | - | -$ 0.17 | - | - |
| Dec 31, 2023 | - | -$ 0.21 | - | - |
| Sep 30, 2023 | - | -$ 0.22 | - | - |
Aardvark Therapeutics, Inc. Common Stock’s stock was trading at $ 1.52 on Nov 12, 2026 a day before the last earnings report was released.
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 0.88 | $ 1.52 | ||
| Aug 11, 2026 | -$ 0.66 | $ 7.56 | $ 6.57 | |
| May 7, 2026 | -$ 0.99 | $ 5.89 | $ 5.44 | |
| Mar 23, 2026 | -$ 0.81 | $ 4.07 | $ 3.77 | |
| Nov 13, 2025 | -$ 0.75 | $ 10.73 | $ 9.92 | |
| Aug 13, 2025 | -$ 0.66 | $ 10.04 | $ 11.26 | |
| May 14, 2025 | -$ 0.71 | $ 10.14 | $ 9.09 | |
| Mar 31, 2025 | -$ 0.44 | $ 7.74 | $ 8.29 | |
| Feb 26, 2025 | -$ 0.68 | $ 13.65 | $ 13.40 |
Aardvark Therapeutics, Inc. Common Stock released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Aardvark Therapeutics, Inc. Common Stock missed analysts’ expectations during the last earnings period by
